| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.HYP.0000190040.66563.04 |
| P698 | PubMed publication ID | 16260641 |
| P2093 | author name string | Thomas Walther | |
| Gerd Wallukat | |||
| Holger Stepan | |||
| Heinz-Peter Schultheiss | |||
| Alexander Jank | |||
| Renaldo Faber | |||
| Sabine Bartel | |||
| P433 | issue | 6 | |
| P304 | page(s) | 1275-1279 | |
| P577 | publication date | 2005-10-31 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | |
| P478 | volume | 46 |
| Q53700889 | AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats. |
| Q37132801 | AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia |
| Q54602344 | AT1-receptor autoantibody: a true causal factor of pre-eclampsia or only a marker of poor placentation? |
| Q36794943 | Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders |
| Q36355165 | Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia |
| Q35699115 | Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy |
| Q35576417 | Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction |
| Q37353499 | Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension |
| Q35701236 | Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice |
| Q33748680 | Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity |
| Q33765684 | Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients |
| Q24605647 | Angiotensin receptors, autoimmunity, and preeclampsia |
| Q37307973 | Are we getting closer to a Nobel prize for unraveling preeclampsia? |
| Q37436219 | Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats |
| Q35681804 | Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling |
| Q37699015 | Characterization of antibody specificities associated with preeclampsia |
| Q26852668 | Elucidating immune mechanisms causing hypertension during pregnancy |
| Q37229246 | Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia |
| Q36380039 | GPCRs as potential therapeutic targets in preeclampsia. |
| Q37447371 | Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. |
| Q37139722 | Identifying immune mechanisms mediating the hypertension during preeclampsia |
| Q34355945 | Increased xanthine oxidase in the skin of preeclamptic women |
| Q37119326 | Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia |
| Q36050775 | Is preeclampsia an autoimmune disease? |
| Q36107337 | Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion |
| Q24649934 | Pathophysiology of placentation abnormalities in pregnancy-induced hypertension |
| Q37114991 | Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections |
| Q35542826 | Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia |
| Q47548339 | Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease |
| Q34151967 | Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations |
| Q37278804 | Potential markers of preeclampsia--a review |
| Q35681821 | Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia |
| Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
| Q37079628 | Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia |
| Q35707881 | Receptor-activating autoantibodies and disease: preeclampsia and beyond |
| Q64907090 | Renin-angiotensin system in pre-eclampsia: everything old is new again. |
| Q34785813 | Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia |
| Q37218199 | Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies |
| Q38693025 | The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia |
| Q57150158 | The role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia |
| Q37088970 | The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia |
| Q37187589 | The two stage model of preeclampsia: variations on the theme |
| Q36699839 | Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia |
Search more.